In contrast, in the TCGA cohort, colorectal cancers with wild type BRAF had TMB above 200 in 16.8% of cases when PIK3CA was mutant and in 7.3% of cases when PIK3CA was wild type (Table 3). This evidence concerns the gene BRAF and colorectal cancer.